Micelle nanotechnology

Proprietary nanotechnology - Micelle delivery system

This novel delivery system enables insoluble active pharmaceuticals to be solubilised into an aqueous formulation.

Our micelle nanotechnology is the subject of a number of granted patents and pending applications relating to a range of compounds.

Micelle nanotechnology entraps hydrophobic drug compounds inside minute particles built up from polymers. This formulation technique can potentially deliver effective concentrations of drugs which would normally be insoluble in aqueous based formulations. The micelles may also protect the entrapped drug from hydrolysis by enzymes or from pH environments and thus enable more active medication to be delivered to their site of action.

We have recently granted Plethora Solutions, a specialist urology company, a licence to progress development of a micellar formulation for treatment of interstitial cystitis and painful bladder syndrome. These conditions are estimated to afflict up to two million women in the United States and Europe.